High-Density Lipoproteins as Biomarkers and Therapeutic Tools

Kyung-Hyun Cho, Professor, LipoLab, Department of Medical Biotechnology, Yeungnam University, Republic of Korea

Preface.- Chapter 1. Understanding HDL:  overview.- 1-1.HDL and disease.- 1-2.HDL functions and clinical applications.- 1-3.HDL composition : apolipoproteins and enzymes.- 1-4.Maturation of HDL.- 1-5.HDL and blood pressure.- Chapter 2. Change of HDL by life style.- 2-1.Exercise and HDL.- 2-2.Smoking and HDL.- 2-3.Elderly’s HDL.- 2-4.HDL depends on body weight.- 2-5.HDL from obese but healthy subject.- 2-6.HDL and apoA-I in smokers’ breast milk.- 2-7.Breast milk from frequent trans fatty acid consumers.- 2-8.HDL in cord blood from small neonates.- Chapter 3. Change of HDL in various diseases.- 3-1.HDL from patients with myocardial infarction.- 3-2.HDL from patients with female angina pectoris.- 3-3.HDL and metabolic syndrome.- 3-4.HDL from male patients with atrial fibrillation.- 3-5.HDL from female patients with atrial fibrillation.- 3-6.HDL from patients with hemorrhagic fever with renal syndrome.- 3-7.HDL from patients with rheumatoid arthritis.- 3-8.HDL and prehypertension.- Chapter 4. Detriment of HDL by pollutant and its evaluation.- 4-1.Particulate matter and HDL.- 4-2.Phthalate and HDL.- 4-3.Cadmium and HDL.- 4-4.Humidifier Sterilizer and HDL.- 4-5.Detection of dysfunctional HDL by microfluidics.- 4-6.Evaluation of dysfunctional HDL using zebrafish embryo.- Chapter 5. Change of HDL by food ingredient.- 5-1.Fructose and apoA-I.- 5-2.Fructose and impairment of HDL functionality.- 5-3.Artificial sweeteners and apoA-I.- 5-4.Artificial sweeteners (aspartame, saccharin) and HDL.- 5-5.Aldoketohexoses and HDL.- 5-6.Iron and HDL.- 5-7.Trans fat and HDL.- 5-8.Salt and HDL 576 p.- Summary and perspectives.